WGRX Overview

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

Wall Street analysts forecast WGRX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for WGRX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Wellgistics Health Inc revenue for the last quarter amounts to 1.56M USD, decreased -85.64

Wellgistics Health Inc. EPS for the last quarter amounts to -0.07 USD, decreased -88.71

Wellgistics Health Inc (WGRX) has 13 emplpoyees as of May 31 2026.

Today WGRX has the market capitalization of 8.60M USD.